TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT00481429

Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“Unable to recruit enough participants”

The sponsor’s own words in the registry.

Life of this trial

2008201020122014201620182020Planned start2007-05 (planned)Registered2007-05-31Withdrawn (as of)2019-07-10

Vital statistics

Status
Withdrawn
Sponsor
Imperial College London
Sponsor type
University, hospital or other
Conditions
Diabetes Mellitus, Type 2
Interventions
Rosiglitazone
Participants
0
Sites
4
Countries
United Kingdom

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.